Merck In $60 Million DTC Ads For Propecia

29 April 1998

Merck & Co has begun a $60 million direct-to-consumer advertisingcampaign to promote its treatment for male pattern baldness Propecia (finasteride 1mg), which will include a 45-second television commercial using the slogan "Helping Make Hair Loss History." Propecia ads will also run in US national daily newspapers and 12 "male-oriented" magazines, according to Advertising Age.

As it will take about three months for any significant data to emerge concerning the progress of Propecia, Merck has also created a program to give updates of estimated sales to help manage consumer expectations during that period.

Paul Kelly of Silvermine Consulting said that Propecia still has some problems to overcome, and noted that, for a cosmetic problem, taking a treatment internally will cause some consumer resistance. He added that it should still provide serious competition for Pharmacia & Upjohn's Rogaine (minoxidil).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight